Recent Advances in Angiogenesis and ... - Bentham Science
Recent Advances in Angiogenesis and ... - Bentham Science Recent Advances in Angiogenesis and ... - Bentham Science
Index Recent Advances in Angiogenesis and Antiangiogenesis, 2009 135 O Osteopontin 10-15 P Platelet derived growth factor 49-50 Plexins 2-7 Proteasome inhibitors 129-130 S Semaphorins 2-7 T Thalidomide 137-138 Thrombospondin-1 112-126 Thymidine phosphorylase/Platelet endothelial cell growth factor 67-79 Thymus 40-53 Tissue repair 13 Tumor angiogenesis 13-14, 23-25, 55-57 Tumor targeting 92-100 Tumor vascular disrupting agents 101-111 Tumor vascular targeting 87-89 V Vascular endothelial growth factor 31-32, 47-48 W Wound repair 23 Z Zebrafish 54-58
- Page 2 and 3: Recent Advances in Angiogenesis and
- Page 4 and 5: FOREWORD It has been known for a ve
- Page 6 and 7: single proangiogenic protein. Howev
- Page 8 and 9: v Vito Pistoia Head, Laboratory of
- Page 10 and 11: 2 Recent Advances in Angiogenesis a
- Page 12 and 13: 10 Recent Advances in Angiogenesis
- Page 14 and 15: 12 Recent Advances in Angiogenesis
- Page 16 and 17: The Role of Mesenchymal Stem Cells
- Page 18 and 19: 30 Recent Advances in Angiogenesis
- Page 20 and 21: 32 Recent Advances in Angiogenesis
- Page 22 and 23: Thymus and Angiogenesis Recent Adva
- Page 24 and 25: 54 Recent Advances in Angiogenesis
- Page 26 and 27: 56 Recent Advances in Angiogenesis
- Page 28 and 29: 60 Recent Advances in Angiogenesis
- Page 30 and 31: Recent Advances in Angiogenesis and
- Page 32 and 33: Role of Thymidine Recent Advances i
- Page 34 and 35: Role of Stromal Cells Recent Advanc
- Page 36 and 37: Recent Advances in Angiogenesis and
- Page 38 and 39: Recent Advances in Angiogenesis and
- Page 40 and 41: Tumor Targeting with Transgenic End
- Page 42 and 43: Recent Advances in Angiogenesis and
- Page 44 and 45: Tumor Vascular Disrupting Agents Re
- Page 46 and 47: 113 Recent Advances in Angiogenesis
- Page 48 and 49: Recent Advances in Angiogenesis and
- Page 50 and 51: Tumour Vascular Disrupting Agents R
Index <strong>Recent</strong> <strong>Advances</strong> <strong>in</strong> <strong>Angiogenesis</strong> <strong>and</strong> Antiangiogenesis, 2009 135<br />
O<br />
Osteopont<strong>in</strong> 10-15<br />
P<br />
Platelet derived growth factor 49-50<br />
Plex<strong>in</strong>s 2-7<br />
Proteasome <strong>in</strong>hibitors 129-130<br />
S<br />
Semaphor<strong>in</strong>s 2-7<br />
T<br />
Thalidomide 137-138<br />
Thrombospond<strong>in</strong>-1 112-126<br />
Thymid<strong>in</strong>e phosphorylase/Platelet endothelial cell growth factor 67-79<br />
Thymus 40-53<br />
Tissue repair 13<br />
Tumor angiogenesis 13-14, 23-25, 55-57<br />
Tumor target<strong>in</strong>g 92-100<br />
Tumor vascular disrupt<strong>in</strong>g agents 101-111<br />
Tumor vascular target<strong>in</strong>g 87-89<br />
V<br />
Vascular endothelial growth factor 31-32, 47-48<br />
W<br />
Wound repair 23<br />
Z<br />
Zebrafish 54-58
Change language